Island Pharmaceuticals Ltd (ASX:ILA) has successfully enrolled its first subjects for a Phase 2b clinical trial to test the ...

Progression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.

Genetically engineered mosquitoes with toxic semen could be a new weapon against tropical disease, Australian scientists said ...

Research collaboration by the Department of Entomology and the U.S. Department of Agriculture creates potential for genetic tools to control disease-spreading ticks.

A genetic biocontrol method which reduces the lifespan of female insects could work as fast as pesticides to reduce ...

SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are go ...